Nanopectra Biosciences - Nanomedicine
|Company:||Nanospectra Biosciences, Inc.||Website:||www.nanospectra.com/|
|Contact:||Glenn Goodrich, Vice President email@example.com||Phone:||713-842-2720|
|General Inquiriesfirstname.lastname@example.org||Address:||8285 El Rio Street, Suite 150 Houston, Texas, USA 77054|
Nanospectra Biosciences was founded to commercialize techniques developed at Rice University for the destruction of solid cancer tumors while minimizing damage to healthy tissue.
Nanomedicine Related Products
AuroLase™ cancer therapy. This therapy consists of nanoshells that concentrate at cancer turmor and when illuminated with a near-infrared laser the nanoshells turn the light into heat to destroy the cancer tumor.
The AuroLase™ cancer therapy was developed from nanoshell technology licensed from Rice University.
Product Development Affiliations
The University of Texas Health Science Center at San Antonio; The University of Texas Southwestern Medical Center in Dallas; and Baylor College of Medicine are participating in a human trial of Nanospectra's AuroLase™ cancer therapy.
Subsidiaries or Parent Company
Primary Investors or Funding Source
Private company, in it's latest round of funding (January, 2009) Nanospectra closed on $1.5 million in series A preferred stock with it's existing investors.